Starbucks to Cease GLP-1 Drug Coverage for Employees, Citing Rising Costs
Starting October, Starbucks will no longer cover GLP-1 weight-loss drugs for its employees, a move that reportedly reflects increasing health costs and a wider trend among employers.
Reported by Times of India
AN
2 min read
Language
